自由呼吸低场强MRI可检测COVID-19感染后持续症状相关的肺功能改变
前瞻性纳入74例COVID-19患者和8名健康志愿者,在感染后平均5个月以0.55 T MRI自由呼吸扫描并结合PREFUL分析提取灌注、通气等功能图。同时存在灌注与流容环相关缺陷的百分比及无缺陷区域百分比是检出持续症状最有信息量的变量,两变量联合评分在健康志愿者、无持续症状患者和持续症状患者间呈一致升高。
要点
- 0.55 T自由呼吸MRI结合PREFUL分析可在感染后平均5个月定量评估肺灌注与通气功能。
- 同时存在灌注与流容环相关缺陷的百分比及无缺陷区域百分比是检出持续症状最有信息量的变量。
- 两变量联合评分从健康志愿者7.7升至无持续症状患者8.2、持续症状患者8.6。
核心结论
- 自由呼吸0.55 T MRI结合PREFUL分析可揭示COVID-19感染后持续症状患者肺功能受损的潜在定量标志物,可能补充形态学影像;尚需未来工作探索其转化相关性和临床意义。
研究设计与样本
- 前瞻性研究,纳入74例COVID-19患者和8名健康志愿者,于感染后平均5个月在0.55 T下以自由呼吸平衡稳态自由进动序列扫描,采用PREFUL技术提取归一化灌注、部分通气及流容环相关性图,并由一名委员会认证放射科医师对形态学涡轮自旋回波图像异常程度评分。
关键影像表现/征象
- 归一化灌注、部分通气及流容环相关性缺陷以及这些指标间的缺陷重叠被量化。
- 形态学异常评分与功能参数相关性差。
诊断标准与关键数值
- 检出持续症状最有信息量的变量为同时存在灌注与流容环相关缺陷的百分比及无这些缺陷区域的百分比。
- 两变量模型在整个数据集上拟合时检出准确率为71.4%。
- 两变量联合评分从健康志愿者7.7升至无持续症状患者8.2、持续症状患者8.6。
- 单一变量在有无持续症状患者间均无显著差异(P > 0.05),而两变量联合评分有显著差异(P < 0.02)。
临床应用与阅片要点
- 作者认为自由呼吸0.55 T MRI结合PREFUL分析所揭示的定量标志物可能补充形态学影像。
- 作者指出未来工作需要探索这些发现的转化相关性和临床意义。
局限性
- 作者指出未来工作需要探索这些发现的转化相关性和临床意义。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: With the COVID-19 pandemic, repetitive lung examinations have become necessary to follow-up symptoms and associated alterations. Low-field MRI, benefiting from reduced susceptibility effects, is a promising alternative for lung imaging to limit radiations absorbed by patients during CT examinations, which also have limited capability to assess functional alterations. The aim of this investigative study was to explore the functional abnormalities that free-breathing 0.55 T MRI in combination with the phase-resolved functional lung (PREFUL) analysis could identify in patients with persistent symptoms after COVID-19 infection.
MATERIALS AND METHODS: Seventy-four COVID-19 patients and 8 healthy volunteers were prospectively scanned in free-breathing with a balanced steady-state free-precession sequence optimized at 0.55 T, 5 months postinfection on average. Normalized perfusion (Q), fractional ventilation (FV), and flow-volume loop correlation (FVLc) maps were extracted with the PREFUL technique. Q, FV, and FVLc defects as well as defect overlaps between these metrics were quantified. Morphological turbo-spin-echo images were also acquired, and the extent of abnormalities was scored by a board-certified radiologist. To investigate the functional correlates of persistent symptoms, a recursive feature elimination algorithm was applied to find the most informative variables to detect the presence of persistent symptoms with a logistic regression model and a cross-validation strategy. All MRI metrics, sex, age, body mass index, and the presence of preexisting lung conditions were included.
RESULTS: The most informative variables to detect persistent symptoms were the percentage of concurrent Q and FVLc defects and of areas free of those defects. A detection accuracy of 71.4% was obtained with these 2 variables when fitting the model on the entire dataset. Although none of the single variables differed between patients with and without persistent symptoms ( P > 0.05), the combined score of these 2 variables did ( P < 0.02). This score also showed a consistent increase from healthy volunteers (7.7) to patients without persistent symptoms (8.2) and with persistent symptoms (8.6). The morphological abnormality score showed poor correlation with the functional parameters.
CONCLUSIONS: Functional pulmonary examinations using free-breathing 0.55 T MRI with PREFUL analysis revealed potential quantitative markers of impaired lung function in patients with persistent symptoms after COVID-19 infection, potentially complementing morphologic imaging. Future work is needed to explore the translational relevance and clinical implication of these findings.
引用
- Lévy S, Heiss R, Grimm R, et al. Free-Breathing Low-Field MRI of the Lungs Detects Functional Alterations Associated With Persistent Symptoms After COVID-19 Infection. Invest Radiol. 2022. PMID: 35640012. doi:10.1097/RLI.0000000000000892
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。